In this issue:
VTE management practices in Australia
Eltrombopag plus standard immunosuppression for aplastic anaemia
High-dose plerixafor for CD34+ cell mobilisation
PLASMIC for rapid assessment in thrombotic microangiopathies
Rivaroxaban vs. aspirin for extended VTE treatment
Adenoviraemia well controlled with brincidofovir in paediatric HCT recipients
Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis
Rescue pomalidomide + dexamethasone in AL amyloidosis
Improved outcomes for newly diagnosed AL amyloidosis
Please login below to download this issue (PDF)